Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
Swiss pharma company navigates a difficult market to pay a negative to zero new issue premium -
Strong name recognition helps Swiss pharma company achieve size at a tight price
-
Novartis spin off looks to build on jubilant reception it had last month in Swissies
-
French biotech company is raising capital for R&D and debt refinancing
-
The Finnish biopharmaceutical company tapped shareholders for capital on Thursday night
-
The €813m deal is multiple times covered
